COSTEM 2023 | Addressing the benefits and drawbacks of academic CAR-T cells
Christian Chabannon
• 21 Oct 2023
Christian Chabannon, MD, PhD, Paoli-Calmettes Institute, Marseille, France, shares some insights into a debate held at this year’s meeting, which addressed the benefits and drawbacks of industry and academic approaches of manufacturing CAR-T cells, and further highlights financial and regulatory challenges associated with the small-scale manufacturing of these agents. This interview took place at The 8th Congress on Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM 2023), held in Berlin, Germany.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
